
    
      This is a protocol to obtain saliva or blood samples from non-cancer affected volunteers aged
      60 years or older, without a history of cancer other than non-melanoma skin cancer. These
      samples will be used in a genomic approach to elucidate novel pathways of cancer
      predisposition.
    
  